[1] Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. Expert Opin Drug Saf,2017,16(2):139-147.
[2] Naisbitt DJ, Nattrass RG, Ogese MO. In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs. Immunol Allergy Clin Am,2014,34(3):691-705.
[3] Bocquet H,Bagot M,Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg,1996,15(4):250-257.
[4] Voore P,Odigwe C,Mirrakhimov AE,et al. DRESS syndrome following metformin administration: a case report and review of the literature. Am J Ther,2016,23(6):e1970-e1973.
[5] Tan SC,Chan GY. Relapsing drug-induced hypersensitivity syndrome. Curr Opin Allergy Clin Immunol, 2016,16(4):333-338.
[6] Usui T,Naisbitt DJ. Human leukocyte antigen and idiosyncratic adverse drug reactions. Drug Metab Pharmacokinet,2017,32(1):21-30.
[7] Palmero D, Castagnino J, Musella RM, et al. Difficult clinical management of anti-tuberculosis DRESS syndrome. Int J Tuberc Lung Dis,2013,17(1):76-78.
[8] Kim H,Bang ES,Lim SK,et al. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report. Int J Clin Pharmacol Ther,2016,54(10):808-815.
[9] Lehloenya RJ, Wallace J, Todd G, et al. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients. Int J Tuberc Lung Dis,2012,16(9):1260-1264.
[10] Passeron T, Ndir MC, Aubron C, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin. Acta Derm Venereol,2004,84(1):92-93.
[11] Choi JH,Heo NY,Park SH,et al. Concomitant drug reaction with eosinophilia and systemic symptom syndrome from ethambutol and autoimmune hepatitis from isoniazid. Korean J Gastroenterol,2016,67(5):267-271.
[12] Spriet S,Banks TA. Drug reaction with eosinophilia and systemic symptoms syndrome. Allergy Asthma Proc,2015,36(6):501-505.
[13] Kim JH,Jang SH,Kim DH,et al. A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid. Ann Allergy Asthma Immunol,2013,110(2):118-119.
[14] Sekine A,Saito T,Ito S,et al. Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome. Respir Investig,2012,50(2):70-75.
[15] Thacker H, Shah M, Tulle R. DRESS syndrome: drug rash with eosinophilia and systemic symptoms. J Assoc Physicians India,2015,63(5):78-79.
[16] Lee JY, Seol YJ, Shin DW, et al. A case of the drug reaction with eosinophilia and systemic symptom (DRESS) following isoniazid treatment. Tuberc Respir Dis (Seoul),2015,78(1):27-30.
[17] Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med,2011,124(7):588-597.
[18] Chen G, He JQ. Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review. Medicine (Baltimore),2017,96(7): e6135.
[19] Bopaka RG, El Khattabi W, Afif H, et al. The "DRESS" syndrome in antituberculosis drugs. Rev Pneumol Clin, 2014,70(3):185-188.
[20] Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy, 2014,69(4):420-437.
[21] Pirmohamed M, Ostrov DA, Park BK. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity. J Allergy Clin Immunol,2015,136(2):236-244.
[22] Silva SA, Figueiredo MM, Carneiro L Neto, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).Rev Assoc Med Bras,2016,62(3):227-230.
[23] Jenkins RE, Yaseen FS, Monshi MM, et al. β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis. Chem Res Toxicol,2013,26(6):963-975.
[24] Schrijvers R, Gilissen L, Chiriac AM, et al. Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back. Clin Transl Allergy,2015,5:31.
[25] Paulmann M, Mockenhaupt M. Severe drug hypersensitivity reactions: clinical pattern, diagnosis, etiology and therapeutic options. Curr Pharm Des,2016,22(45):6852-6861.
[26] Pavlos R, Mallal S, Ostrov D, et al. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract,2014, 2(1):21-33.
[27] Shiohara T, Ushigome Y, Kano Y, et al. Crucial role of viral reactivation in the development of severe drug eruptions: a comprehensive review. Clin Rev Allergy Immunol,2015,49(2):192-202.
[28] Ye YM,Hur GY,Kim SH,et al. Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome. Br J Dermatol,2017,176(2):378-386.
[29] Kim SH,Lee SK,Kim SH,et al. Antituberculosis drug-induced hypersensitivity syndrome and its association with human leukocyte antigen.Tuberculosis (Edinb),2013,93(2):270-274.
[30] Usui T,Meng X,Saide K,et al. From the cover: characterization of isoniazid-specific T-cell clones in patients with anti-tuberculosis drug-related liver and skin injury. Toxicol Sci,2017,155(2):420-431.
[31] White KD, Chung WH, Hung SI,et al. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. J Allergy Clin Immunol,2015,136(2):219-234.
[32] 刘鸿凌,赖荣陶,温晓玉. 肝细胞适应及再次给药可能的危险性. 肝脏,2016,21(5):391-392.
[33] 刘备,丁鹏,冯国清. 抗结核药物肝损伤研究进展. 海峡药学,2016,28(3):5-9.
[34] 赵红,程澄,谢雯,等. 抗结核药物致肝损伤的发病机制. 中国肝脏病杂志(电子版), 2015, 7(4):11-13.
[35] Yamada S,Tang M,Richardson K,et al.Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.Pharmacogenomics,2009,1O(9):1433-1445.
[36] 陈成伟. 重视药物性肝损伤免疫机制的研究.肝脏,2016,21(5):397-398.
[37] 赖荣陶,陈军,郭晓燕. 免疫介导的药物性肝损伤. 肝脏,2016,21(5):396-397.
[38] 林森,薛飞平,唐少华. CYP2C19基因多态性与结核病患者药物性肝损伤的关系.上海预防医学,2015,27(4):198-201.
[39] Sousa-Pinto B,Correia C,Gomes L,et al. HLA and delayed drug-induced hypersensitivity. Int Arch Allergy Immunol,2016,170(3):163-179.
[40] Komatsu-Fujii T, Kaneko S, Chinuki Y, et al. Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions. Allergol Int,2017,66(1):116-122.
[41] Wang F,Cai R,He D,et al. Serum IFN-γ-inducible chemokines CXCL9 and CXCL10 are elevated in non-immediate drug hypersensitivity reactions. Asian Pac J Allergy Immunol,2016,34(3):236-241.
[42] Skowron F,Bensaid B,Balme B,et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol,2015,29(11):2199-2205.
[43] Toujani S,Zaiem A,Mjid M,et al. Drug rash with eosinophilia and systemic symptoms to antituberculosis treatment. Tunis Med,2015,93(10):590-593.
[44] Husain Z,Reddy BY,Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. J Am Acad Dermatol,2013,68(5):709.
[45] Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med,2003,139(8):683-693.
[46] Shebe K, Ngwanya MR, Gantsho N, et al. Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man. Contact Dermatitis, 2014,70(2):125-127.
[47] Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet,2016,387(10024): 1211-1226.
[48] Lehloenya RJ, Dlamini S, Muloiwa R, et al. Therapeutic trial of rifabutin after rifampicin-associated DRESS syndrome in tuberculosis-human immunodeficiency virus coinfected patients. Open Forum Infect Dis,2016,3(3):ofw130.
[49] Arruti N, Villarreal O, Bernedo N, et al. Positive allergy study (intradermal, patch, and lymphocyte transformation tests) in a case of isoniazid-induced DRESS. J Investig Allergol Clin Immunol,2016,26(2):119-120.
[50] Cheng J, Rawal S, Roberts A, et al. Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications. Pediatr Infect Dis J, 2013,32(12):1388-1390.
[51] Katsube O, Anzai M, Nomura Y, et al. A case of drug-induced hypersensitivity syndrome caused by levofloxacin used for treating pulmonary tuberculosis. Kekkaku,2014,89(2):51-56.
[52] Lee JH, Park HK, Heo J, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci,2008,23(3): 521-525. |